This CME-certified activity provides a training forum for the exchange of ideas and information on the diagnosis and treatment of chronic kidney disease and associated secondary hyperparathyroidism, cardiovascular risk factors, and accompanying effects on bone metabolism.
Participants gain detailed insight into therapeutic options for treating secondary hyperparathyroidism, for correcting Ca, P, and PTH levels and for reducing cardiovascular risk factors and altered bone metabolism.
